We, the people of America, demand reform of ; Kentucky Cabinet for Families and Children


Among Bevin’s campaign pledges was that he would reform the cabinet’s social services agency.
By:  Robin Rider-Osborne·Sunday, January 31, 2016
KENTUCKY REPRESENTATIVE EMAIL ADDRESSES AND ANNOUNCEMENT LETTER / ALL STATE PARTICIPATION. Copy and paste letter to email addresses listed below; Bulk email dump at bottom of page for one letter bulk sending.
We, the people of America, demand reform of ; Kentucky Cabinet for Families and Children & Family Law courtrooms. I request of your office the following;
1. Implement removal of Abusers, not children from Family units.
2. Remove Immunity for Kentucky Cabinet for Families and Children workers.
3. Restructure Family Law court into budget cutting mediation forums of two party negotiations.
4. Redirect Family Law Criminal allegations into Criminal court.
5. Restrict Judges and various interpretations of Family Law codes to abuse either party.
6. End Kentucky Cabinet for Families and Children abuse and Family Law abuse against the people of Kentucky. We demand an end to wasteful spending on agencies devastating families financially.
7 Allow a Jury trial in Termination of Parental Rights Cases
8. Amend or repeal that law that allows for children being removed due to disability and termination of rights without working towards reunification.
9. Release records upon request without redaction and revamp the Ombudsman to process the complaints in a timely and proper manner.
10. Revamp Foster Care Review boards as originally spelled out in CAPTA.
I cite the cases of ;
Pike Co. Circuit Judge Steve Combs DUI,
Garrard Co. Judge Ronnie Lane Drug trafficking,
Russell Co. Judge R. Maricle illegally distributing prescription drugs,
Judge Charles Huffman Extortion,
Russell Co. Judge Executive Kent Clark, Alcohol related charges,
Judge Executive Joe Grieshop charged with third-degree burglary; theft of items valued at over $10,000; 10 counts of retaliating against participants in a legal process; and one count of official misconduct,
Knox Co. Judge executive Raymond Smith(deceased)Attempted murder of Robin Smith, Murder of Mychael Smith and Micheal Smith,
Warren Co. Judge Margaret Huddleston DUI,
Marshall Co. Judge Executive Mike Miller, False entry/unauthorized act, .
This partial list of neglect of office, unethical professional conduct and evidence of failure within the Judicial branch of Kentucky. We strongly oppose Judges overseeing Families in crisis in the Family law division.
I cite the case of the failure of Kentucky Cabinet of Families and Children in protecting a nine year old, Amy from her adoptive siblings, known to have history in sexual abuse and undisclosed by the KCFC prior to the adoption. Problems were reported to indicate the adoptive parent, Kimberly Dye desire to ‘return’ the adopted girl shortly before her death This was an enormous failure of several to ignore all the warning signs of this broken adoptive home. While we acknowledge review and actions were taken as the result of the death of this girl, we feel more can be done to insure the safety of children seized and accountability by this agency.
We know there is rampant corruption in the government offices of Child services and Family law. This is a national epidemic of criminal activity within the programs, courtrooms and agencies that are bankrupting the American Families. We demand reform and strict laws on government seats of power placed with the power of office to seize children, financially destroy individuals, and racketeering to conceal internal corruption within our state and federal offices.
End legal abuse by Judges and Lawyers by instituting forums for successful dissolution/custody between spouses with guidelines without ruling Judges or lawyers. Enforce penalty of perjury, redirect criminal actions in Family Law to the Criminal courts. Remove immunity for Judges operating outside the rule of law. Reform Child services to an efficient team of child crime investigators and not our out dated model of Child protective services.
We, the people, unite and demand reform of CPS agencies and Family Law practices. We, the people, take back our rights to protect our children and families.
Robin Rider-Osborne can be contacted at:
Citizens Investigating the “Runaway Cabinet of Kentucky” Task Force
and by email to:  [email protected]
Thank You for your attention in this matter!
EMAIL LINKS (EMAIL BULK DUMP AT BOTTOM OF PAGE / WINDOWS LINK EMAILS BELOW SITE LINKS. COPY /CUT PASTE LETTER BODY INTO EACH EMAIL LINK. NOT ALL REPRESENTATIVES PROVIDE EMAIL ADDRESSES.
BULK EMAIL DUMP / ONE SENDER; ONE EMAIL
[email protected];[email protected];[email protected];[email protected];[email protected]; [email protected];[email protected];[email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]
This issue was submitted by Robin Rider-Osborne, Lexington, KY.

My Grandson came over the other day

 
Jimmy D Lawson

1 hr ·

How Will You Answer?
By J. L. (Max) Brewster

My Grandson came over the other day
He’s grown up now and I’m old and gray
Asking Grandpa, why did you give my freedom away?
With a trembling voice, this is all I could say
I tried my hardest, I protested, I wrote
To my Congressman, Senators, and I did always vote
I learned about issues, the Constitution, and more
I thought of your brother and cousin, I’ll stop this I swore
I found like minded people but our numbers were few
We gathered together, got involved, we all knew
That our republic was dying the Constitution was dead
Put down by elitists and those who wore red
I did all I could and I’m sorry my son
Tears rolled down my face, I wish we had won
He gave me a hug, said I’m proud Grandpa to know
That you tried your hardest, wouldn’t let freedom go
I thought of his question I wished would have been
Grandpa what saved the republic? How did you win?
You had no money, connections or clout
How did this happen? What was it about?
I told him how corruption had swept over the land
People gathered together, they marched hand in hand
To the Capitol in Washington, then their state, then their town
Once involved and informed no one could keep them down
We chose principled leaders to take up the fight
Against power, corruption, and to do what was right
Things started to change rather quickly at first
Freedom flooding the land like a dam that had burst
Government shrunk smaller and smaller, it was amazing to see
Bureaucrats getting their pink slips instead of you and me
Businesses started to prosper and many came back
The reason? No magic, just much lower tax
I came back to reality my heart sank like a stone
Back to reality, no freedom, I’m chilled to the bone
The government runs everything they knock on my door
Inspecting my thermostat, my light bulbs and more
I still keep on thinking and remembering a time
When I was truly free and my property was mine
But my Grandson knows one thing that he is not free
No, not like I was and he is beginning to see
That maybe its possible to once more light that spark
Of freedom and liberty that will light up the dark
And maybe his generation will turn the spark to a flame
That went out under my watch, I still am to blame
So when your Grandson comes to you a generation from now
What will he say? Will he ask how
Did you lose my freedom? Why didn’t you fight?
Or will he say? I love you Grandpa, thank you for protecting my rights

This Week at the State Capitol

January 25-29, 2016

FRANKFORT — Getting our financial house in order.

That was a theme Gov. Matt Bevin returned to several times as he gave his first budget address on Tuesday night during a joint session of the Kentucky General Assembly.

The governor’s State of the Commonwealth Budget Address unveiled a two-year spending plan that calls for 9 percent cuts across state government with the much of the savings aimed at helping state pension systems meet obligations.

In addition to the proposed 9 percent cuts over the next two fiscal years, the governor also announced 4.5 percent budget cuts for the final half of the current fiscal year.

Not all parts of state government would be hit by cuts under the governor’s spending plan. The main school funding formula, known as SEEK, is spared. So is Medicaid, Veterans Affairs, school district health insurance, student financial aid and more.

While budget cuts would be widespread, the governor’s spending plan calls for increased spending for some front-line public servants including the Kentucky State Police and other peace officers, social workers, public defenders, correctional officers and others.

Now that the governor has delivered his spending plan, it’s time for lawmakers to take the proposal apart and reassemble it in a manner they are satisfied with. The state budget bill is currently in the House, where budget subcommittees will dig into all parts of the budget in the weeks to come. Once the House approves a spending plan, it will be the Senate’s turn. By session’s end, Senate and House members are expected to meet in conference committee meetings to iron out differences in each chamber’s preferred spending plans. With the 2016 session scheduled to adjourn on April 12, there’s much work to do in the time available.

As lawmakers focused on budget issues this week, they also continued moving a number of bills through the legislative process, including legislation on the following topics:

Informed Consent. A consultation between a woman seeking an abortion and a health care provider would have to occur during an in-person meeting or through real-time video conferencing under the version of Senate Bill 4 approved by the House this week. The version of the bill approved by the Senate last week called for in-person consultations but did not provide the videoconferencing option. Information is already legally required to be provided to women seeking abortions 24 hours before the procedure, but currently the info is sometimes delivered over the phone rather than in person. Senate Bill 4 has returned to the Senate for consideration of the House changes to the legislation.

CPR. A bill that would require public high school students to learn CPR passed the state Senate this week. Senate Bill 33 as amended would require CPR be taught in physical education, health or junior ROTC classes in either ninth, 10th, 11th or 12th grade. The bill has been sent to the House for consideration.

Minimum wage. The state’s minimum hourly wage would be raised to $10.10 over the next two and half years under a bill that cleared a House committee this week and is now awaiting consideration by the full House. House Bill 278 would increase Kentucky’s current minimum wage of $7.25 an hour to $8.20 this August, $9.15 in July 2017 and $10.10 in July 2018. The increase would not apply to businesses that have a recent average annual gross volume of sales of less than $500,000.

Concealed carry. Senate Joint Resolution 36 urges Virginia, which borders Eastern Kentucky, to restore a so-called reciprocal agreement that allowed Kentucky concealed carry permit holders to legally carry a concealed firearm in Virginia. The legislation was approved in the Senate this week and has been sent to the House for consideration.

Infant protection. Parents of newborns would have up to 30 days to surrender their baby at a state-approved safe place without facing criminal charges under legislation approved by the House this week. Current law gives parents 72 hours after a child is born to leave the baby at a hospital, police or fire station or with emergency medical services personnel if they feel unable to care for the child. House Bill 97 would expand that to 30 days and add churches or other places of worship to the list of approved safe places where a child could be surrendered. Parents would not face charges for surrendering the baby as long as the child is not injured. The bill has been sent to the Senate for consideration.

Feedback on the issues under consideration can be shared with lawmakers by calling the General Assembly’s toll-free message line at 800-372-7181.

Indica, Sativa, Ruderalis – Did We Get It All Wrong?

By: Mitchell Colbert

Indica, Sativa, Ruderalis - Did We Get It All Wrong, Source: https://s3.amazonaws.com/leafly/content/sativa-indica-and-hybrid-whats-the-difference-between-cannabis-ty/primary.jpg

Since the 1970s, cannabis has been divided into three sub-species (often confused as different species), C. indica, C. sativa, C. ruderalis, with ruderalis largely being considered ‘wild cannabis,’ not fit for medicinal or recreational uses. A common lay-persons distinction is between marijuana, which is bred for high cannabinoid content, and hemp, which is bred for industrial uses like fiber.

Any of the three subspecies can be bred as a hemp or marijuana plant. John McPartland, a researcher affiliated with GW Pharmaceuticals, presented a study at the 2014 meeting of the International Cannabis Research Society,  proposing a new nomenclature for cannabis. The original report on O’Shaughnessy’s contains more information than I can reproduce here, and has a wonderful chart; it is definitely worth your time to read.

It seems Richard Evans Schultes, the man who created the original taxonomy for cannabis in the 1970s, misidentified a C. afghanica plant as a C. indica plant. That one mistake began 40 years of confusion which has only been dispelled by McPartland’s research this year.

McPartland was the first researcher to look at the genetic markers on the three subspecies of cannabis using the plant’s genome to conclusively identify where it originated. He also proved conclusively that they are all the same species, just different subspecies. As it turns out, C. sativa should have been identified as C. indica, because it originated in India (hence indica). C. indica should have been identified as C. afghanica, because it actually originated in Afghanistan. Finally, it seems that C. ruderalis is actually what people mean when they refer to C. sativa.

If that sounds confusing, refer to this handy table, or the original chart.

Cannabis Indica (Formerly Sativa)

Origin: India

Morphology: Taller (>1.5m) than their short and stocky Afghanica cousins, with sparser branches and less dense buds/flowers.

Physiology: Longer flowering time, between nine and fourteen weeks. Minimal frost tolerance with a moderate production of resin.

Chemistry: Much greater THC than CBD and other cannabinoids, this leads to the “head high” many users report.

Psychoactivity: Stimulating.

Cannabis Afghanica (Formerly Indica)

Origin: Central Asia (Afghanistan, Turkestan, Pakistan)

Morphology: Shorter (<1.5m) than Indica strains with dense branches with wider leaves, and much denser buds/flowers

Physiology: Shorter flowering time, as little as seven to nine weeks. Good frost tolerance with high resin production. Afghanica strains can be susceptible to mold due to how dense the buds and branches are.

Chemistry: More variable than Indica strains. THC is often still the predominant cannabinoid but some strains have 1:1 ratios and some may have even higher CBD than THC.

Psychoactivity: Sedating.

Cannabis Sativa (Formerly Ruderalis)

Origin: Usually feral or wild. From Europe or Central Asia.

Morphology: Variable, depending on origin.

Physiology: The flowering time is short and variable, many varieties exhibit autoflowering traits (flowering independently of sun cycles). Moderate frost tolerance with relatively low resin production.

Chemistry: More CBD than THC. Prominent terpenes include caryophyllene and myrcene, giving these strains a floral flavor and scent.

Psychoactivity: Usually lacking.

This new nomenclature should come to replace the old system, because it is grounded in the actual genetics of the plant and is scientifically sound. Despite that, it is likely that this new naming scheme will face resistance from cannabis users and those in the medical cannabis industry who will have become used to decades of convention firmly establishing an inaccurate taxonomy.

This is reminiscent of the Brontosaurus, a dinosaur that never existed but we were all taught in school it was real, or the former 9th planet of Pluto (now a ‘dwarf planet’). Sometimes science gets it wrong and it is up to modern scientists with better methods, like McPartland, to correct our old mistakes.

The difficult part will be getting mass acceptance of his newly proposed taxonomy. What seems likely is that a split may develop between academics and laymen, with academics adopting the new system and laymen continuing to adhere to the old system, at least for a few more years.

Perhaps in time C. afghanica, C. indica, and C. sativa will come into the vogue, but that largely depends on the willingness of the medical cannabis industry to adopt this new system and thus pass it on to the patients and growers. But it seems unlikely that the cannabis industry would wholeheartedly jump on board, given the risk that this new nomenclature could confuse patients who may be used to seeing only “indicas” and “sativas” on the shelf.

Time will tell.

CONTINUE READING…

Kentucky to potientially become buds with bud

Posted by Julia Dake | Jan 28, 2016

Julia Dake, Staff Writer

No pun intended, but I think it’s high time weed became legalized in Kentucky.

Marijuana legalization has made some significant headway over the past few years, now legal for recreational use in four states and medicinal use in 25. Pretty soon another state, namely Kentucky, could be added to the list, either for medicinal and recreational use.

The Cannabis Freedom Act, a bill filed by state Senator Perry B. Clark of Louisville, would repeal Kentucky’s current ban on marijuana and legalize sales to people 21 and over, while those under age 21 could use it with a doctor’s prescription.

Taxes generated from the sale of marijuana would go toward a variety of government programs, including need-based scholarships to Kentucky students pursuing a college degrees. These taxes would also generate revenue for Support Educational Excellence in Kentucky (SEEK), which provides money for Kentucky’s school districts and grants to police departments to purchase gear.

In addition to the fact that we live in the 21st century, the tax revenue would greatly benefit Kentucky students seeking a college education. Tuition costs rise every year, putting college out of reach for some, and further stressing those already enrolled. So given the chance to alleviate some of the financial burden on students, why are some legislators so hesitant?

Legalizing weed would also promote tourism in Kentucky, seeing that we would be the first state on the Eastern seaboard where recreational marijuana would be legal. This would become an added incentive for people visiting our state, and would help the hospitality and tourism industries flourish. Not to mention, the state is ideally suited to grow marijuana. We used to be one of the top hemp producing states, which suggests that we just might be a pretty good at growing its more heady cousin.

Critics of marijuana legalization argue that not enough research has been done and that legalization could lead to the potential for marijuana monopolies, making it difficult to regulate. While these are valid concerns, proponents of the Cannabis Freedom Act have added clauses that would create a three-tier system, preventing any one entity from monopolizing all the facets of marijuana cultivation and sales. Senator Clark insists that marijuana would be regulated exactly like alcohol is, requiring an ID to purchase through licensed dealers.

The bottom line is Kentuckians are using marijuana every day and a lot of money is changing hands. So why not set it up so a portion of that money goes to help the state?

CONTINUE READING…

Indica, Sativa, Ruderalis – Did We Get It All Wrong?

By: Mitchell Colbert

Indica, Sativa, Ruderalis - Did We Get It All Wrong, Source: https://s3.amazonaws.com/leafly/content/sativa-indica-and-hybrid-whats-the-difference-between-cannabis-ty/primary.jpg

Since the 1970s, cannabis has been divided into three sub-species (often confused as different species), C. indica, C. sativa, C. ruderalis, with ruderalis largely being considered ‘wild cannabis,’ not fit for medicinal or recreational uses. A common lay-persons distinction is between marijuana, which is bred for high cannabinoid content, and hemp, which is bred for industrial uses like fiber.

Any of the three subspecies can be bred as a hemp or marijuana plant. John McPartland, a researcher affiliated with GW Pharmaceuticals, presented a study at the 2014 meeting of the International Cannabis Research Society,  proposing a new nomenclature for cannabis. The original report on O’Shaughnessy’s contains more information than I can reproduce here, and has a wonderful chart; it is definitely worth your time to read.

It seems Richard Evans Schultes, the man who created the original taxonomy for cannabis in the 1970s, misidentified a C. afghanica plant as a C. indica plant. That one mistake began 40 years of confusion which has only been dispelled by McPartland’s research this year.

McPartland was the first researcher to look at the genetic markers on the three subspecies of cannabis using the plant’s genome to conclusively identify where it originated. He also proved conclusively that they are all the same species, just different subspecies. As it turns out, C. sativa should have been identified as C. indica, because it originated in India (hence indica). C. indica should have been identified as C. afghanica, because it actually originated in Afghanistan. Finally, it seems that C. ruderalis is actually what people mean when they refer to C. sativa.

If that sounds confusing, refer to this handy table, or the original chart.

Cannabis Indica (Formerly Sativa)

Origin: India

Morphology: Taller (>1.5m) than their short and stocky Afghanica cousins, with sparser branches and less dense buds/flowers.

Physiology: Longer flowering time, between nine and fourteen weeks. Minimal frost tolerance with a moderate production of resin.

Chemistry: Much greater THC than CBD and other cannabinoids, this leads to the “head high” many users report.

Psychoactivity: Stimulating.

Cannabis Afghanica (Formerly Indica)

Origin: Central Asia (Afghanistan, Turkestan, Pakistan)

Morphology: Shorter (<1.5m) than Indica strains with dense branches with wider leaves, and much denser buds/flowers

Physiology: Shorter flowering time, as little as seven to nine weeks. Good frost tolerance with high resin production. Afghanica strains can be susceptible to mold due to how dense the buds and branches are.

Chemistry: More variable than Indica strains. THC is often still the predominant cannabinoid but some strains have 1:1 ratios and some may have even higher CBD than THC.

Psychoactivity: Sedating.

Cannabis Sativa (Formerly Ruderalis)

Origin: Usually feral or wild. From Europe or Central Asia.

Morphology: Variable, depending on origin.

Physiology: The flowering time is short and variable, many varieties exhibit autoflowering traits (flowering independently of sun cycles). Moderate frost tolerance with relatively low resin production.

Chemistry: More CBD than THC. Prominent terpenes include caryophyllene and myrcene, giving these strains a floral flavor and scent.

Psychoactivity: Usually lacking.

This new nomenclature should come to replace the old system, because it is grounded in the actual genetics of the plant and is scientifically sound. Despite that, it is likely that this new naming scheme will face resistance from cannabis users and those in the medical cannabis industry who will have become used to decades of convention firmly establishing an inaccurate taxonomy.

This is reminiscent of the Brontosaurus, a dinosaur that never existed but we were all taught in school it was real, or the former 9th planet of Pluto (now a ‘dwarf planet’). Sometimes science gets it wrong and it is up to modern scientists with better methods, like McPartland, to correct our old mistakes.

The difficult part will be getting mass acceptance of his newly proposed taxonomy. What seems likely is that a split may develop between academics and laymen, with academics adopting the new system and laymen continuing to adhere to the old system, at least for a few more years.

Perhaps in time C. afghanica, C. indica, and C. sativa will come into the vogue, but that largely depends on the willingness of the medical cannabis industry to adopt this new system and thus pass it on to the patients and growers. But it seems unlikely that the cannabis industry would wholeheartedly jump on board, given the risk that this new nomenclature could confuse patients who may be used to seeing only “indicas” and “sativas” on the shelf.

Time will tell.

CONTINUE READING…

Cannabis-Related Disorders

images8

Background

In January, 2014, Colorado became the first state in the United States to legalize marijuana for recreational purposes, marking the beginning of what will likely become the end of marijuana prohibition. Marijuana was legal in the United States until 1937, when Congress passed the Marijuana Tax Act, effectively making the drug illegal. The American Medical Association (AMA) opposed the legislation at the time of its passage. Additionally, from 1850-1942, marijuana was listed in the US Pharmacopoeia, the official list of recognized medical drugs . Cannabis was marketed as extract or tincture by several pharmaceutical companies and used for ailments such as anxiety and lack of appetite.

Despite the medical establishment’s views on the benefits of marijuana, the passage of the Comprehensive Drug Abuse Prevention and Control Act of 1970 classified marijuana as a Schedule I drug, defined as a category of drugs not considered legitimate for medical use. Other Schedule I drugs include heroin, phencyclidine(PCP), and lysergic acid diethylamide (LSD).[1]

A significant paradox and disconnect continues to exist between the federal government’s outdated policies versus changing state laws, the general public’s perception and acceptance of marijuana, and even the President himself. In discussing his own marijuana use with New Yorker editor David Remnick, President Obama commented, "As has been well documented, I smoked pot as a kid, and I view it as a bad habit and a vice, not very different from the cigarettes that I smoked as a young person up through a big chunk of my adult life. I don’t think it is more dangerous than alcohol." He elaborated that marijuana was actually less dangerous than alcohol "in terms of its impact on the individual consumer."[2]

Currently, 21 states have legalized marijuana for medicinal purposes, with many others actively considering the issue. Additionally, a recent survey by NBC News/The Wall Street Journal shows that the majority of Americans support legalizing marijuana.[3] Recent federal policy changes have attempted to redress the inconsistencies between federal and state law. In 2009, the Justice Department issued a federal medical marijuana policy memo to the Drug Enforcement Administration (DEA), Federal Bureau of Investigation (FBI), and US Attorneys instructing prosecutors not to target medicinal marijuana patients and their providers for federal prosecution in states where medicinal marijuana has been legalized. In the summer of 2010, the Department of Veteran Affairs issued a department directive to "formally allow patients treated at its hospitals and clinics to use medical marijuana in states where it is legal, a policy clarification that veterans have sought for years."[4]

In the Netherlands, where the distribution of marijuana has been legalized, the effect of decriminalization has had little effect on the consumption rate of cannabis.[5] In 2004, Reinarman et al looked at the consumption of marijuana rates between San Francisco and Amsterdam to see what effect decriminalization had on these different populations.[6] The results showed that the consumption habits between the two populations were negligible. Little evidence has shown that the decriminalization of cannabis has changed the consumption habits of the populations involved.[7]

While there is a rich history of anecdotal accounts of the benefits of marijuana and a long tradition of marijuana being used for a variety of ailments, the scientific literature in support of medicinal uses of marijuana is less substantial. Considered one of the first scientifically valid papers in support of marijuana’s medicinal benefit, in 2007, Dr. Donald Abrams and colleagues published the results of a randomized placebo-controlled trial examining the effect of smoked cannabis on the neuropathic pain of HIV-associated sensory neuropathy and an experimental pain model. The authors concluded that smoked cannabis effectively relieved chronic neuropathic pain in HIV-associated sensory neuropathy and was well tolerated by patients. The pain relief was comparable to chronic neuropathic pain treated with oral drugs.[8]

According to Harvard Medical School’s April, 2010 edition of the Harvard Mental Health Letter[9] : Consensus exists that marijuana may be helpful in treating certain carefully defined medical conditions. In its comprehensive 1999 review, for example, the Institute of Medicine (IOM) concluded that marijuana may be modestly effective for pain relief (particularly nerve pain), appetite stimulation for people with AIDS wasting syndrome, and control of chemotherapy-related nausea and vomiting.

These widely held beliefs in the medical community supporting the medicinal benefit of marijuana are starting to gain support in the form of rigorous empirical evidence demonstrating its clinical benefit and limited potential for harm. In 2012, the AMA published a landmark study that followed more than 5,000 patients longitudinally over 20 years. The results of the study were somewhat surprising. Although many had assumed that regular exposure to marijuana smoke would result in pulmonary function damage, similar to the deleterious effects seen with regular tobacco smoke exposure, the study convincingly demonstrated that regular exposure to marijuana smoke did not adversely affect lung function. Even more surprising, regular marijuana smokers demonstrated increased total lung function capacity.

The authors report, “Marijuana may have beneficial effects on pain control, appetite, mood, and management of other chronic symptoms. Our findings suggest that occasional use of marijuana for these or other purposes may not be associated with adverse consequences on pulmonary function.”[10]

The AMA is urging the federal government to change the classification of marijuana from a Schedule I drug to enable further clinical research on marijuana. Additionally, Harvard Mental Health Letter’s authors point out that while marijuana works to relieve pain, suppress nausea, reduce anxiety, improve mood, and act as a sedative, the evidence that marijuana may be an effective treatment for psychiatric indications is inconclusive.[11]

In a recently published systematic review published as a “Report of the Guideline Development Subcommittee of the American Academy of Neurology”, the authors performed a systematic review of medical marijuana from 1948 to November 2013 to identify the role of medical marijuana in the treatment of multiple sclerosis (MS), epilepsy and, movement disorders. The authors concluded that medical marijuana was found to be effective for treating MS-related pain or painful spasms.[11]

While marijuana may have medicinal benefits, its use in excess by some individuals can lead to marked impairment in social and occupational functioning. Published in 2013, the fifth edition of TheDiagnostic and Statistical Manual of Mental Disorders (DSM-5) included significant changes to substance-related and addictive disorders. DSM-5 combined the previously separate categories of substance abuse and dependence into a single disorder of substance use, specific to the substance (eg, Alcohol Use Disorder, Cannabis Use Disorder)

DSM-5 recognizes the following 5 cannabis-associated disorders[12] :

  • Cannabis Use Disorder

  • Cannabis Intoxication

  • Cannabis Withdrawal

  • Other Cannabis-Induced Disorders

  • Unspecified Cannabis-Related Disorder

CONTINUE READING….

Please review the article in it’s entirety online thru link above.  There are many people vying for the "Cannabis use disorder" syndrome for the purpose of promoting physician care and pharmaceutical drugs. In my opinion this is because they need something new to pick up the slack in their business because Cannabis legalization  is continuing to grow across the Nation.

Be aware of what your Physician is trying to do to you with this Diagnosis code which will be permanently instilled into your medical records, along with your prescription drug use thru the monitoring programs now in existence.

We are being wrapped up nice and tight with a new bow tie….CANNABIS ABUSE.

These additional articles previously posted on site are also related to this issue: (smk)

http://kentuckymarijuanaparty.com/2015/06/26/marijuana-addiction-drug-research-gets-3-million-grant-as-obama-encourages-legalization/

http://kentuckymarijuanaparty.com/2015/06/26/the-protection-of-commerce-in-the-form-of-pharmaceutical-industrial-complex/

http://kentuckymarijuanaparty.com/2015/06/22/docs-dont-like-medical-marijuana/

http://kentuckymarijuanaparty.com/2013/01/06/patrick-kennedy-on-marijuana-former-rep-leads-campaign-against-legal-pot/

http://kentuckymarijuanaparty.com/2012/07/13/why-do-clinics-deny-painkillers-to-medical-marijuana-patients/

http://kentuckymarijuanaparty.com/2012/05/30/government-forced-nci-to-censor-medical-cannabis-facts/

http://kentuckymarijuanaparty.com/2015/09/24/all-roads-in-kentucky-lead-you-through-hell/

http://kentuckymarijuanaparty.com/2015/09/14/a-summary-of-two-doctors/

Donors flocked to Matt Bevin after he won election

Republican Gov. Matt Bevin delivers his budget before a joint legislative session in the House Chambers at the Kentucky State Capitol, Tuesday, Jan. 26, 2016, in Frankfort, Ky. Bevin’s first budget won’t take effect until July 1, but the new governor is not waiting to slash government spending.

Republican Gov. Matt Bevin delivers his budget before a joint legislative session in the House Chambers at the Kentucky State Capitol, Tuesday, Jan. 26, 2016, in Frankfort, Ky. Bevin’s first budget won’t take effect until July 1, but the new governor is not waiting to slash government spending. Timothy D. Easley Associated Press

By John Cheves

[email protected]

Frankfort

Gov. Matt Bevin’s 2015 campaign collected more than $115,000 after he was elected, allowing about 150 donors — including Frankfort lobbyists, state employees, coal executives and business owners with an interest in state government — to help him pay off his creditors. Many wrote $1,000 checks during Bevin’s first month as governor.

Some are recent converts, having financially backed Democratic nominee Jack Conway in last year’s general election, or Republican candidate James Comer in the GOP primary. Once the ballots were counted Nov. 3, they wrote their first checks to Bevin, the new Republican governor.

“What can I say about this?” said Mason Routt of Versailles, chief executive of CAL Laboratory Services. Routt gave $2,000 to Conway before the election. On Nov. 16, he and his wife gave $2,000 to Bevin. “In an effort to promote bipartisanship and show that we can all come together, we need to support he who is in office. How’s that?”

The question now: Will the governor, with the power to award state contracts and appointments and regulate industries, ask donors to cover the $1.57 million he personally lent to his largely self-financed campaign? As of Jan. 2, that debt remained on the books.

Bevin spokeswoman Jessica Ditto declined to comment Thursday on the governor’s post-election campaign fundraising.

Whatever fundraising Bevin does in coming months, it will happen privately. No longer in a gubernatorial election year, Bevin doesn’t have to file another finance report disclosing his donors until Nov. 11. His last filing — called a 60-day post-election report — was received Jan. 7, covering the first month of his administration.

Typically, the 60-day post-election report is where a campaign puts its affairs in order and dissolves, said John Steffen, executive director of the Kentucky Registry of Election Finance. But Bevin’s campaign stayed active. It took in more than $10,000 on Dec. 30 alone, and it sent out final payments to campaign workers, pollsters, strategists and other creditors. Its biggest unfinished business now is Bevin’s outstanding personal loan.

Steffen said Bevin doesn’t have to close his 2015 campaign committee unless he wants to raise money for a future run for office — say, for re-election in 2019 — which would require him to start fresh with a new committee.

“His case is a little unusual,” Steffen said. If Bevin’s 2015 campaign continues to take money during 2016, “there will be a reporting gap there. But there is no provision in the law requiring him to report until November.”

The idea that for the next 10 months we’re not going to know who is giving money to the state’s chief executive is just unacceptable.

Richard Beliles, chairman of ethics watchdog Common Cause of Kentucky

Read more here: http://www.kentucky.com/news/politics-government/article57095013.html#storylink=cpy

Cannabis-Related Disorders

images8

Background

In January, 2014, Colorado became the first state in the United States to legalize marijuana for recreational purposes, marking the beginning of what will likely become the end of marijuana prohibition. Marijuana was legal in the United States until 1937, when Congress passed the Marijuana Tax Act, effectively making the drug illegal. The American Medical Association (AMA) opposed the legislation at the time of its passage. Additionally, from 1850-1942, marijuana was listed in the US Pharmacopoeia, the official list of recognized medical drugs . Cannabis was marketed as extract or tincture by several pharmaceutical companies and used for ailments such as anxiety and lack of appetite.

Despite the medical establishment’s views on the benefits of marijuana, the passage of the Comprehensive Drug Abuse Prevention and Control Act of 1970 classified marijuana as a Schedule I drug, defined as a category of drugs not considered legitimate for medical use. Other Schedule I drugs include heroin, phencyclidine(PCP), and lysergic acid diethylamide (LSD).[1]

A significant paradox and disconnect continues to exist between the federal government’s outdated policies versus changing state laws, the general public’s perception and acceptance of marijuana, and even the President himself. In discussing his own marijuana use with New Yorker editor David Remnick, President Obama commented, "As has been well documented, I smoked pot as a kid, and I view it as a bad habit and a vice, not very different from the cigarettes that I smoked as a young person up through a big chunk of my adult life. I don’t think it is more dangerous than alcohol." He elaborated that marijuana was actually less dangerous than alcohol "in terms of its impact on the individual consumer."[2]

Currently, 21 states have legalized marijuana for medicinal purposes, with many others actively considering the issue. Additionally, a recent survey by NBC News/The Wall Street Journal shows that the majority of Americans support legalizing marijuana.[3] Recent federal policy changes have attempted to redress the inconsistencies between federal and state law. In 2009, the Justice Department issued a federal medical marijuana policy memo to the Drug Enforcement Administration (DEA), Federal Bureau of Investigation (FBI), and US Attorneys instructing prosecutors not to target medicinal marijuana patients and their providers for federal prosecution in states where medicinal marijuana has been legalized. In the summer of 2010, the Department of Veteran Affairs issued a department directive to "formally allow patients treated at its hospitals and clinics to use medical marijuana in states where it is legal, a policy clarification that veterans have sought for years."[4]

In the Netherlands, where the distribution of marijuana has been legalized, the effect of decriminalization has had little effect on the consumption rate of cannabis.[5] In 2004, Reinarman et al looked at the consumption of marijuana rates between San Francisco and Amsterdam to see what effect decriminalization had on these different populations.[6] The results showed that the consumption habits between the two populations were negligible. Little evidence has shown that the decriminalization of cannabis has changed the consumption habits of the populations involved.[7]

While there is a rich history of anecdotal accounts of the benefits of marijuana and a long tradition of marijuana being used for a variety of ailments, the scientific literature in support of medicinal uses of marijuana is less substantial. Considered one of the first scientifically valid papers in support of marijuana’s medicinal benefit, in 2007, Dr. Donald Abrams and colleagues published the results of a randomized placebo-controlled trial examining the effect of smoked cannabis on the neuropathic pain of HIV-associated sensory neuropathy and an experimental pain model. The authors concluded that smoked cannabis effectively relieved chronic neuropathic pain in HIV-associated sensory neuropathy and was well tolerated by patients. The pain relief was comparable to chronic neuropathic pain treated with oral drugs.[8]

According to Harvard Medical School’s April, 2010 edition of the Harvard Mental Health Letter[9] : Consensus exists that marijuana may be helpful in treating certain carefully defined medical conditions. In its comprehensive 1999 review, for example, the Institute of Medicine (IOM) concluded that marijuana may be modestly effective for pain relief (particularly nerve pain), appetite stimulation for people with AIDS wasting syndrome, and control of chemotherapy-related nausea and vomiting.

These widely held beliefs in the medical community supporting the medicinal benefit of marijuana are starting to gain support in the form of rigorous empirical evidence demonstrating its clinical benefit and limited potential for harm. In 2012, the AMA published a landmark study that followed more than 5,000 patients longitudinally over 20 years. The results of the study were somewhat surprising. Although many had assumed that regular exposure to marijuana smoke would result in pulmonary function damage, similar to the deleterious effects seen with regular tobacco smoke exposure, the study convincingly demonstrated that regular exposure to marijuana smoke did not adversely affect lung function. Even more surprising, regular marijuana smokers demonstrated increased total lung function capacity.

The authors report, “Marijuana may have beneficial effects on pain control, appetite, mood, and management of other chronic symptoms. Our findings suggest that occasional use of marijuana for these or other purposes may not be associated with adverse consequences on pulmonary function.”[10]

The AMA is urging the federal government to change the classification of marijuana from a Schedule I drug to enable further clinical research on marijuana. Additionally, Harvard Mental Health Letter’s authors point out that while marijuana works to relieve pain, suppress nausea, reduce anxiety, improve mood, and act as a sedative, the evidence that marijuana may be an effective treatment for psychiatric indications is inconclusive.[11]

In a recently published systematic review published as a “Report of the Guideline Development Subcommittee of the American Academy of Neurology”, the authors performed a systematic review of medical marijuana from 1948 to November 2013 to identify the role of medical marijuana in the treatment of multiple sclerosis (MS), epilepsy and, movement disorders. The authors concluded that medical marijuana was found to be effective for treating MS-related pain or painful spasms.[11]

While marijuana may have medicinal benefits, its use in excess by some individuals can lead to marked impairment in social and
occupational functioning. Published in 2013, the fifth edition of TheDiagnostic and Statistical Manual of Mental Disorders (DSM-5) included significant changes to substance-related and addictive disorders. DSM-5 combined the previously separate categories of substance abuse and dependence into a single disorder of substance use, specific to the substance (eg, Alcohol Use Disorder, Cannabis Use Disorder)

DSM-5 recognizes the following 5 cannabis-associated disorders[12] :

  • Cannabis Use Disorder

  • Cannabis Intoxication

  • Cannabis Withdrawal

  • Other Cannabis-Induced Disorders

  • Unspecified Cannabis-Related Disorder

CONTINUE READING….

Please review the article in it’s entirety online thru link above.  There are many people vying for the "Cannabis use disorder" syndrome for the purpose of promoting physician care and pharmaceutical drugs. In my opinion this is because they need something new to pick up the slack in their business because Cannabis legalization  is continuing to grow across the Nation.

Be aware of what your Physician is trying to do to you with this Diagnosis code which will be permanently instilled into your medical records, along with your prescription drug use thru the monitoring programs now in existence.

We are being wrapped up nice and tight with a new bow tie….CANNABIS ABUSE.

These additional articles previously posted on site are also related to this issue: (smk)

http://kentuckymarijuanaparty.com/2015/06/26/marijuana-addiction-drug-research-gets-3-million-grant-as-obama-encourages-legalization/

http://kentuckymarijuanaparty.com/2015/06/26/the-protection-of-commerce-in-the-form-of-pharmaceutical-industrial-complex/

http://kentuckymarijuanaparty.com/2015/06/22/docs-dont-like-medical-marijuana/

http://kentuckymarijuanaparty.com/2013/01/06/patrick-kennedy-on-marijuana-former-rep-leads-campaign-against-legal-pot/

http://kentuckymarijuanaparty.com/2012/07/13/why-do-clinics-deny-painkillers-to-medical-marijuana-patients/

http://kentuckymarijuanaparty.com/2012/05/30/government-forced-nci-to-censor-medical-cannabis-facts/

http://kentuckymarijuanaparty.com/2015/09/24/all-roads-in-kentucky-lead-you-through-hell/

http://kentuckymarijuanaparty.com/2015/09/14/a-summary-of-two-doctors/

The state’s minimum hourly wage would be raised to $10.10 over the next two and half years under a bill that cleared a House committee today

Please note: This is a revised version of a news release that was sent within the past hour. This version clarifies that the proposed minimum wage increase would not apply to businesses with annual gross volume of sales of less than $500,000.

For Immediate Release

January 28, 2016

State minimum wage increase proposal moves to House floor

FRANKFORT—The state’s minimum hourly wage would be raised to $10.10 over the next two and half years under a bill that cleared a House committee today.

House Bill 278, sponsored by House Speaker Greg Stumbo, D-Prestonsburg, would increase Kentucky’s current minimum wage of $7.25 an hour to $8.20 this August, $9.15 in July 2017 and $10.10 in July 2018. The increase would not apply to businesses that have a recent average annual gross volume of sales of less than $500,000.

Stumbo said HB 278, if passed into law, would put an extra $2,000 or so a year into the pockets of Kentucky minimum wage workers. Those workers now earn around $15,000 annually for full-time work, he said.

“Can you live on that? I don’t think so,” the Speaker said to House Labor and Industry Committee members. The bill also includes language prohibiting wage discrimination based on race, gender, or national origin.

Kentucky’s current minimum wage, which mirrors the federal minimum wage, has not increased since 2009. That increase was approved by the Kentucky General Assembly in 2007. Only Louisville and Lexington have approved a minimum wage above the state rate.

Twenty nine states and Washington D.C. now have a minimum wage above Kentucky’s minimum wage and the federal minimum wage, according to the National Conference of State Legislatures.

Lawmakers voicing concerns with HB 278 included Rep. Jerry Miller, R-Eastwood, who said some surrounding states, including Virginia and Indiana, have the same minimum wage rate as Kentucky. Miller expressed concern that companies may move their business across the border if a Kentucky minimum wage increase were passed.

“The market’s the best way to raise wages,” said Miller.

Representatives from the Kentucky Chamber of Commerce, Kentucky Retail Federation and the Kentucky office of the National Federation of Independent Business also spoke in opposition to the bill.

Stumbo responded that 13 states have raised their minimum wage since 2014 and the unemployment rate in every one of those states has fallen in the past year and half.

HB 278 now goes to the full House for consideration.

-END-